Transmedics Group Stock Analysis
| TMDX Stock | USD 147.66 0.34 0.23% |
IPO Date 2nd of May 2019 | 200 Day MA 125.6646 | 50 Day MA 133.7291 | Beta 1.955 |
TransMedics Group holds a debt-to-equity ratio of 0.36. At this time, TransMedics' Long Term Debt is fairly stable compared to the past year. Short and Long Term Debt Total is likely to rise to about 493.2 M in 2026, despite the fact that Net Debt is likely to grow to (17.7 M). With a high degree of financial leverage come high-interest payments, which usually reduce TransMedics' Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
TransMedics' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. TransMedics' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps TransMedics Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect TransMedics' stakeholders.
For many companies, including TransMedics, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for TransMedics Group, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, TransMedics' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 14.1431 | Enterprise Value Ebitda 38.3809 | Price Sales 8.3532 | Shares Float 33.1 M | Wall Street Target Price 157.5455 |
TransMedics Group is overvalued with Real Value of 138.05 and Target Price of 157.55. The main objective of TransMedics stock analysis is to determine its intrinsic value, which is an estimate of what TransMedics Group is worth, separate from its market price. There are two main types of TransMedics' stock analysis: fundamental analysis and technical analysis.
The TransMedics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. TransMedics is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. TransMedics Stock trading window is adjusted to America/New York timezone.
TransMedics | Build AI portfolio with TransMedics Stock |
TransMedics Stock Analysis Notes
About 97.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years. TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company was founded in 1998 and is headquartered in Andover, Massachusetts. Transmedics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 148 people. To find out more about TransMedics Group contact the company at 978 552 0900 or learn more at https://www.transmedics.com.TransMedics Quarterly Total Revenue |
|
TransMedics Group Investment Alerts
| Over 97.0% of the company shares are owned by institutional investors | |
| Latest headline from prnewswire.com: TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635 |
TransMedics Largest EPS Surprises
Earnings surprises can significantly impact TransMedics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-24 | 2024-12-31 | 0.22 | 0.19 | -0.03 | 13 | ||
2020-03-02 | 2019-12-31 | -0.39 | -0.43 | -0.04 | 10 | ||
2022-08-01 | 2022-06-30 | -0.35 | -0.41 | -0.06 | 17 |
TransMedics Environmental, Social, and Governance (ESG) Scores
TransMedics' ESG score is a quantitative measure that evaluates TransMedics' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of TransMedics' operations that may have significant financial implications and affect TransMedics' stock price as well as guide investors towards more socially responsible investments.
TransMedics Stock Institutional Investors
| Shares | Hood River Capital Management Llc | 2025-12-31 | 690.4 K | Eventide Asset Management, Llc | 2025-12-31 | 548.3 K | Morgan Stanley - Brokerage Accounts | 2025-09-30 | 547.8 K | Marshall Wace Asset Management Ltd | 2025-09-30 | 541.7 K | Dimensional Fund Advisors, Inc. | 2025-12-31 | 489.7 K | Two Sigma Investments Llc | 2025-12-31 | 436 K | Wellington Management Company Llp | 2025-12-31 | 433.3 K | T. Rowe Price Associates, Inc. | 2025-09-30 | 398.2 K | Amvescap Plc. | 2025-09-30 | 385.8 K | Blackrock Inc | 2025-09-30 | 5.3 M | Fmr Inc | 2025-12-31 | 5.1 M |
TransMedics Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.06 B.TransMedics Profitablity
The company has Profit Margin (PM) of 0.31 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.18 | 0.19 | |
| Return On Capital Employed | 0.11 | 0.12 | |
| Return On Assets | 0.18 | 0.19 | |
| Return On Equity | 0.40 | 0.34 |
Management Efficiency
TransMedics Group has return on total asset (ROA) of 0.0725 % which means that it generated a profit of $0.0725 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.5424 %, meaning that it created $0.5424 on every $100 dollars invested by stockholders. TransMedics' management efficiency ratios could be used to measure how well TransMedics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, TransMedics' Return On Tangible Assets are fairly stable compared to the past year. Return On Capital Employed is likely to rise to 0.12 in 2026, whereas Return On Equity is likely to drop 0.34 in 2026. At this time, TransMedics' Asset Turnover is fairly stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 13.92 | 14.61 | |
| Tangible Book Value Per Share | 13.52 | 14.20 | |
| Enterprise Value Over EBITDA | 27.72 | 29.11 | |
| Price Book Value Ratio | 8.74 | 9.18 | |
| Enterprise Value Multiple | 27.72 | 29.11 | |
| Price Fair Value | 8.74 | 9.18 | |
| Enterprise Value | 3.7 B | 3.9 B |
Management at TransMedics Group focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Technical Drivers
As of the 5th of March, TransMedics has the Risk Adjusted Performance of 0.0226, semi deviation of 2.4, and Coefficient Of Variation of 4884.12. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of TransMedics Group, as well as the relationship between them.TransMedics Group Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Double Exponential Moving Average indicator was developed by Patrick Mulloy. It consists of a single exponential moving average and a double exponential moving average. This indicator is more responsive to TransMedics Group changes than the simple moving average.
TransMedics Group Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific TransMedics insiders, such as employees or executives, is commonly permitted as long as it does not rely on TransMedics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases TransMedics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
TransMedics Outstanding Bonds
TransMedics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. TransMedics Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most TransMedics bonds can be classified according to their maturity, which is the date when TransMedics Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
TransMedics Predictive Daily Indicators
TransMedics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of TransMedics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 23600.44 | |||
| Daily Balance Of Power | (0.07) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 148.46 | |||
| Day Typical Price | 148.19 | |||
| Price Action Indicator | (0.97) | |||
| Period Momentum Indicator | (0.34) | |||
| Relative Strength Index | 13.14 |
TransMedics Corporate Filings
F4 | 4th of March 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 27th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 24th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 20th of February 2026 Other Reports | ViewVerify | |
F3 | 12th of February 2026 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 4th of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 12th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 5th of December 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
TransMedics Forecast Models
TransMedics' time-series forecasting models are one of many TransMedics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary TransMedics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.TransMedics Bond Ratings
TransMedics Group financial ratings play a critical role in determining how much TransMedics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for TransMedics' borrowing costs.| Piotroski F Score | 5 | Healthy | View |
| Beneish M Score | (2.98) | Unlikely Manipulator | View |
TransMedics Group Debt to Cash Allocation
As TransMedics Group follows its natural business cycle, the capital allocation decisions will not magically go away. TransMedics' decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
TransMedics Group currently holds 469.69 M in liabilities with Debt to Equity (D/E) ratio of 0.36, which is about average as compared to similar companies. TransMedics Group has a current ratio of 11.87, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about TransMedics' use of debt, we should always consider it together with its cash and equity.TransMedics Total Assets Over Time
TransMedics Assets Financed by Debt
The debt-to-assets ratio shows the degree to which TransMedics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.TransMedics Debt Ratio | 33.0 |
TransMedics Corporate Bonds Issued
TransMedics Long Term Debt
Long Term Debt |
|
About TransMedics Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how TransMedics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling TransMedics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as TransMedics. By using and applying TransMedics Stock analysis, traders can create a robust methodology for identifying TransMedics entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 0.18 | 0.19 | |
| Operating Profit Margin | 0.18 | 0.19 | |
| Net Profit Margin | 0.31 | 0.33 | |
| Gross Profit Margin | 0.60 | 0.42 |
Current TransMedics Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. TransMedics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. TransMedics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 157.55 | Strong Buy | 9 | Odds |
Most TransMedics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand TransMedics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of TransMedics Group, talking to its executives and customers, or listening to TransMedics conference calls.
TransMedics Stock Analysis Indicators
TransMedics Group stock analysis indicators help investors evaluate how TransMedics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading TransMedics shares will generate the highest return on investment. By understating and applying TransMedics stock analysis, traders can identify TransMedics position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 337.1 M | |
| Long Term Debt | 502.4 M | |
| Common Stock Shares Outstanding | 40.5 M | |
| Total Stockholder Equity | 473.1 M | |
| Total Cashflows From Investing Activities | -59.3 M | |
| Tax Provision | -82.8 M | |
| Quarterly Earnings Growth Y O Y | 11.881 | |
| Property Plant And Equipment Net | 332.8 M | |
| Cash And Short Term Investments | 488.4 M | |
| Cash | 488.4 M | |
| Accounts Payable | 10.3 M | |
| Net Debt | -18.7 M | |
| 50 Day M A | 133.7291 | |
| Total Current Liabilities | 89.3 M | |
| Other Operating Expenses | 496.9 M | |
| Non Current Assets Total | 430.6 M | |
| Forward Price Earnings | 63.6943 | |
| Non Currrent Assets Other | 739 K | |
| Stock Based Compensation | 36.9 M |
Additional Tools for TransMedics Stock Analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.